Research Atlas · source screening

Anidulafungin

An attributable first-pass index of PubMed records whose titles name this governed identity. Records are sorted by publication date, not by evidence strength. Inclusion does not establish efficacy, safety, or a clinical indication.

Title-search results

354

Shown with stable PMIDs

25

Search recorded

2026-09-26

Source: NCBI PubMed / MEDLINE · exact query: "Anidulafungin"[Title] · up to 25 recent title matches per identity. Each result links to its PubMed record.

1. In Vitro Activity and In Vivo Efficacy in a Murine Model of Rezafungin, Anidulafungin, Caspofungin, and Micafungin Against the Fifth Clade of Candida (Candidozyma) auris.

   J Fungi (Basel) · 2026 Jul 24 · PMID 42646079 · DOI 10.3390/jof12080552

   Source metadata only · evidence grade unassigned · scientific conclusions pending review

2. Clinical Outcomes of Micafungin and Anidulafungin in Candidozyma auris (Formerly Candida auris) Candidemia: A Propensity Score-Matched Retrospective Cohort Study.

   J Fungi (Basel) · 2026 Jul 22 · PMID 42506298 · DOI 10.3390/jof12070537

   Source metadata only · evidence grade unassigned · scientific conclusions pending review

3. Correction: Comparative real-world safety profiles of caspofungin, micafungin, and anidulafungin: a disproportionality analysis based on FAERS and VigiAccess databases.

   Front Pharmacol · 2026 · PMID 42524035 · DOI 10.3389/fphar.2026.1916009

   Source metadata only · evidence grade unassigned · scientific conclusions pending review

4. Comparative real-world safety profiles of caspofungin, micafungin, and anidulafungin: a disproportionality analysis based on FAERS and VigiAccess databases.

   Front Pharmacol · 2026 · PMID 42394979 · DOI 10.3389/fphar.2026.1840717

   Source metadata only · evidence grade unassigned · scientific conclusions pending review

5. Intravitreal rezafungin and anidulafungin in a rabbit model of Aspergillus fumigatus endophthalmitis.

   Sci Rep · 2026 May 27 · PMID 42191760 · DOI 10.1038/s41598-026-53347-0

   Source metadata only · evidence grade unassigned · scientific conclusions pending review

6. Evaluation of the Synergistic Activity of Anidulafungin with Isavuconazole, Voriconazole, Posaconazole, and Amphotericin B in Candida auris (Candidozyma auris) Isolates.

   Infect Drug Resist · 2026 · PMID 41835197 · DOI 10.2147/IDR.S585235

   Source metadata only · evidence grade unassigned · scientific conclusions pending review

7. A Calcineurin Inhibitor as an Enhancer of Candida Susceptibility to Anidulafungin.

   ACS Omega · 2026 Feb 10 · PMID 41696345 · DOI 10.1021/acsomega.5c10111

   Source metadata only · evidence grade unassigned · scientific conclusions pending review

8. Identification of claramine and anidulafungin as entry inhibitors of Crimean-Congo hemorrhagic fever virus.

   Antiviral Res · 2026 Feb · PMID 41519386 · DOI 10.1016/j.antiviral.2026.106343

   Source metadata only · evidence grade unassigned · scientific conclusions pending review

9. Rapid detection of anidulafungin and fluconazole susceptibility profiles of clinical Candida strains by MALDI-TOF MS.

   Acta Microbiol Immunol Hung · 2025 Nov 27 · PMID 41171318 · DOI 10.1556/030.2025.02678

   Source metadata only · evidence grade unassigned · scientific conclusions pending review

10. Minimum Inhibitory Concentrations of Anidulafungin as a Potential Predictor of Biocide Susceptibility of Clade 1 Candidozyma (Candida) auris Isolates.

    Microbiologyopen · 2025 Oct · PMID 41121674 · DOI 10.1002/mbo3.70093

    Source metadata only · evidence grade unassigned · scientific conclusions pending review

11. Candida parapsilosis and echinocandins: should the clinical laboratory drop anidulafungin Etest from the susceptibility testing panel?

    Antimicrob Agents Chemother · 2025 Aug 6 · PMID 40590712 · DOI 10.1128/aac.00241-25

    Source metadata only · evidence grade unassigned · scientific conclusions pending review

12. Caspofungin versus anidulafungin in patients with invasive candidiasis: a retrospective study with propensity-score-matched analysis.

    Ther Adv Infect Dis · 2025 Jan-Dec · PMID 40761894 · DOI 10.1177/20499361251344777

    Source metadata only · evidence grade unassigned · scientific conclusions pending review

13. Evaluating the Efficacy and Safety of Anidulafungin and Caspofungin in Invasive Candida Infections in Intensive Care Units in India: A Prospective, Observational, Multicenter, Open-Label Study.

    Cureus · 2025 Jul · PMID 40821127 · DOI 10.7759/cureus.88039

    Source metadata only · evidence grade unassigned · scientific conclusions pending review

14. Synthetic Human Lactoferrin Peptide hLF(1-11) Shows Antifungal Activity and Synergism with Fluconazole and Anidulafungin Towards Candida albicans and Various Non-Albicans Candida Species, Including Candidozyma auris.

    Antibiotics (Basel) · 2025 Jul 2 · PMID 40723974 · DOI 10.3390/antibiotics14070671

    Source metadata only · evidence grade unassigned · scientific conclusions pending review

15. Anidulafungin exposure and population pharmacokinetics in critically ill patients with invasive candidiasis.

    Infection · 2025 Jun · PMID 39641856 · DOI 10.1007/s15010-024-02448-x

    Source metadata only · evidence grade unassigned · scientific conclusions pending review

16. Anidulafungin is a useful surrogate marker for predicting in vitro susceptibility to rezafungin among five Candida species using CLSI methods and interpretive criteria.

    J Clin Microbiol · 2025 Feb 19 · PMID 39840977 · DOI 10.1128/jcm.01129-24

    Source metadata only · evidence grade unassigned · scientific conclusions pending review

17. Echinocandins Pharmacokinetics: A Comprehensive Review of Micafungin, Caspofungin, Anidulafungin, and Rezafungin Population Pharmacokinetic Models and Dose Optimization in Special Populations.

    Clin Pharmacokinet · 2025 Jan · PMID 39707078 · DOI 10.1007/s40262-024-01461-5

    Source metadata only · evidence grade unassigned · scientific conclusions pending review

18. Efficacity of anidulafungin in the treatment of Candida endophthalmitis.

    J Fr Ophtalmol · 2025 Jan · PMID 39353804 · DOI 10.1016/j.jfo.2024.104306

    Source metadata only · evidence grade unassigned · scientific conclusions pending review

19. Evaluation of clinical outcomes of anidulafungin for the treatment of candidemia in hospitalized critically ill patients with obesity: A multicenter, retrospective cohort study.

    Int J Infect Dis · 2024 Nov · PMID 39241957 · DOI 10.1016/j.ijid.2024.107234

    Source metadata only · evidence grade unassigned · scientific conclusions pending review

20. In Vivo Efficacy of Rezafungin, Anidulafungin, Caspofungin, and Micafungin against Four Candida auris Clades in a Neutropenic Mouse Bloodstream Infection Model.

    J Fungi (Basel) · 2024 Aug 29 · PMID 39330378 · DOI 10.3390/jof10090617

    Source metadata only · evidence grade unassigned · scientific conclusions pending review

21. Repurposing Anidulafungin for Alzheimer's Disease via Fragment-Based Drug Discovery.

    ACS Chem Neurosci · 2024 Aug 21 · PMID 39096284 · DOI 10.1021/acschemneuro.4c00150

    Source metadata only · evidence grade unassigned · scientific conclusions pending review

22. In Vitro Activitiy of Rezafungin in Comparison with Anidulafungin and Caspofungin against Invasive Fungal Isolates (2017 to 2022) in China.

    J Fungi (Basel) · 2024 May 31 · PMID 38921383 · DOI 10.3390/jof10060397

    Source metadata only · evidence grade unassigned · scientific conclusions pending review

23. Anidulafungin.

    Journal not recorded · 2006 · PMID 37247354

    Source metadata only · evidence grade unassigned · scientific conclusions pending review

24. Anidulafungin Levels in Breast Milk After Cessation of Treatment: A Case Report.

    Breastfeed Med · 2024 Feb · PMID 38174985 · DOI 10.1089/bfm.2023.0246

    Source metadata only · evidence grade unassigned · scientific conclusions pending review

25. Comparison of amphotericin B lipid complex, deoxycholate amphotericin B, fluconazole, and anidulafungin activity against Candida albicans biofilm isolated from breakthrough candidemia.

    Enferm Infecc Microbiol Clin (Engl Ed) · 2023 Dec · PMID 36707288 · DOI 10.1016/j.eimce.2022.07.009

    Source metadata only · evidence grade unassigned · scientific conclusions pending review